Davenport & CO LLC Sangamo Therapeutics, Inc Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Davenport & CO LLC holds 13,500 shares of SGMO stock, worth $28,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,500

Previous 13,500 -0.0%

Holding current value

$28,890

Previous $4,000 175.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$0.3 - $0.63 $10,080 - $21,168	-33,600 Reduced 71.34%	13,500 $7,000
Q3 2023 Oct 17, 2023	SELL	$0.58 - $1.47 $12,296 - $31,164	-21,200 Reduced 31.04%	47,100 $28,000
Q2 2023 Jul 20, 2023	SELL	$1.11 - $1.74 $10,767 - $16,878	-9,700 Reduced 12.44%	68,300 $88,000
Q1 2023 Apr 27, 2023	SELL	$1.66 - $3.67 $166 - $367	-100 Reduced 0.13%	78,000 $137,000
Q4 2022 Jan 20, 2023	SELL	$2.77 - $5.07 $98,058 - $179,478	-35,400 Reduced 31.19%	78,100 $0
Q3 2022 Oct 11, 2022	BUY	$4.27 - $6.39 $33,306 - $49,842	7,800 Added 7.38%	113,500 $556,000
Q2 2022 Jul 18, 2022	BUY	$3.28 - $6.21 $3,280 - $6,210	1,000 Added 0.96%	105,700 $438,000
Q1 2022 May 02, 2022	SELL	$5.23 - $7.82 $5,230 - $7,820	-1,000 Reduced 0.95%	104,700 $608,000
Q4 2021 Feb 10, 2022	SELL	$7.29 - $10.97 $160,380 - $241,340	-22,000 Reduced 17.23%	105,700 $793,000
Q3 2021 Oct 14, 2021	SELL	$9.01 - $12.01 $4,505 - $6,005	-500 Reduced 0.39%	127,700 $1.15 Million
Q1 2021 Apr 28, 2021	SELL	$10.88 - $17.05 $39,657 - $62,147	-3,645 Reduced 2.76%	128,200 $1.61 Million
Q4 2020 Jan 13, 2021	SELL	$9.23 - $18.18 $36,920 - $72,720	-4,000 Reduced 2.94%	131,845 $2.06 Million
Q3 2020 Oct 15, 2020	SELL	$9.38 - $12.48 $142,576 - $189,696	-15,200 Reduced 10.06%	135,845 $1.28 Million
Q2 2020 Jul 28, 2020	SELL	$6.21 - $11.83 $184,716 - $351,883	-29,745 Reduced 16.45%	151,045 $1.35 Million
Q1 2020 May 05, 2020	BUY	$5.05 - $8.85 $199,550 - $349,707	39,515 Added 27.97%	180,790 $1.15 Million
Q4 2019 Jan 22, 2020	SELL	$8.03 - $11.7 $2.28 Million - $3.32 Million	-283,526 Reduced 66.74%	141,275 $1.18 Million
Q2 2019 Jul 10, 2019	BUY	$8.75 - $13.03 $3.11 Million - $4.64 Million	355,876 Added 516.32%	424,801 $4.58 Million
Q1 2019 Apr 17, 2019	BUY	$7.72 - $12.81 $6,948 - $11,529	900 Added 1.32%	68,925 $658,000
Q4 2018 Jan 28, 2019	SELL	$9.51 - $16.6 $961,318 - $1.68 Million	-101,085 Reduced 59.77%	68,025 $781,000
Q3 2018 Oct 11, 2018	BUY	$13.05 - $19.05 $1.35 Million - $1.97 Million	103,510 Added 157.79%	169,110 $2.87 Million
Q2 2018 Jul 09, 2018	BUY	$13.9 - $19.8 $1,390 - $1,980	100 Added 0.15%	65,600 $932,000
Q1 2018 Apr 04, 2018	BUY	$16.7 - $26.35 $258,850 - $408,425	15,500 Added 31.0%	65,500 $1.24 Billion
Q3 2017 Oct 12, 2017	BUY	$8.4 - $15.0 $420,000 - $750,000	50,000	50,000 $750 Million

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $335M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account